Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Official title: Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients
Although significant progress has been made in understanding vitiligo, managing the condition remains a challenge. Many treatments can achieve noticeable repigmentation (over 75%) on areas like the face and neck. However, nearly 40% of patients experience a relapse within the first year after stopping treatment.
Pierre Fabre Laboratories are testing their topical product, RV5098A, designed specifically for people with vitiligo. They believe it could help maintain pigmentation in areas that have already been successfully repigmented, especially for adults with facial vitiligo.
Participants will be recruited through the investigator’s outpatient clinic or the center’s database. Those who meet the basic eligibility criteria may be contacted via phone, email, or letter to discuss joining the study.
For a detailed list of eligibility criteria, interested individuals are encouraged to contact the study team or visit the trial’s official page. Only the research staff can confirm if someone is fully eligible to participate.
Start date: 2024-05-23
Completion date: 2025-06-01
Contact: Christophe CHAMARD
Tel.: +335.34.50.65.88
Email: christophe.chamard@pierre-fabre.com
Link: https://clinicaltrials.gov/study/NCT06446063
FAQOther Questions
- Shall I try low-fat diet for my vitiligo?
The link between dietary fat and autoimmune diseases like vitiligo is a compelling yet complex puzzle that continues to intrigue scientists. While the conversation is ongoing, o...
- Awareness Days Similar to World Vitiligo Day
World Vitiligo Day, celebrated annually on June 25 since 2012, is a significant event dedicated to raising awareness about vitiligo and supporting those affected by the conditio...
- Polypodium leucotomos as an adjunct treatment for vitiligo?
The tropical fern Polypodium leucotomos (also known as Polypodium aureum) and its relative Polypodium decumanumhave shown potential benefits for managing vitiligo and other auto...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.